Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis

Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis

Epitope mapping of anti-Ro52 antibodies (Abs) has been extensively studied in patients with Sjögren's syndrome (SjS) and systemic lupus erythematosus (SLE). Comprehensive epitope mapping in systemic sclerosis (SSc), where anti-Ro52 antibodies are also frequently detected, has not been performed...

Full description

Bibliographic Details
Main Authors: Athanasios Gkoutzourelas, Christos Liaskos, Maria G. Mytilinaiou, Theodora Simopoulou, Christina Katsiari, Alexandra Tsirogianni, Dimitrios Daoussis, Thomas Scheper, Wolfgang Meyer, Dimitrios P. Bogdanos, Lazaros I. Sakkas
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Immunology
Subjects:
autoantibody
autoimmunity
autoimmune rheumatic diseases
epitope
SS-A
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02835/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.02835/full

Similar Items